CJC-1295 + Ipamorelin 

High-purity peptide blend supplied for laboratory research purposes.

This research formulation combines CJC-1295 and Ipamorelin in a single preparation for use in experimental models investigating peptide signalling, receptor interactions, and endocrine-related biological pathways. The combination is commonly utilised in preclinical research examining the interaction of multiple peptide compounds within controlled laboratory settings.

Research Focus Areas

• Investigated in studies involving GHRH and growth hormone secretagogue receptor (GHSR) signalling pathways
• Utilised in research examining peptide-receptor interactions and cellular communication
• Studied in laboratory models exploring endocrine and metabolic signalling mechanisms
• Commonly used in multi-peptide research applications and pathway analysis

Product Information

• Total Peptide Content: 10 mg
• Blend of CJC-1295 and Ipamorelin
• High-purity research-grade material
• Supplied as a lyophilised powder
• Intended for laboratory and analytical research applications only

Handling & Reconstitution Information

Due to the stability profile of this compound, research protocols may require reconstitution using a mixture of 1 part acetic acid and 2 parts bacteriostatic water.

Researchers should validate preparation methods and storage conditions appropriate to their specific experimental requirements. Improper handling, storage, or reconstitution procedures may affect compound stability and research consistency.

Disclaimer

For laboratory research use only.

Not for human consumption. Not for therapeutic, diagnostic, veterinary, or clinical use. This product has not been evaluated by the Therapeutic Goods Administration (TGA). Not intended to diagnose, treat, cure, or prevent any disease.